<DOC>
	<DOCNO>NCT00093184</DOCNO>
	<brief_summary>The purpose study demonstrate benefit bivalirudin combination clopidogrel provisional GPIIb/IIIa inhibitor use , reduce bleed complication associate early invasive management patient present ST Elevation Myocardial Infarction ( STEMI ) undergo primary PCI , provide similar rate ischemic event compare publish result relevant trial .</brief_summary>
	<brief_title>Bivalirudin Patients With Acute Myocardial Infarction ( AMI ) Undergoing Primary PCI</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>1 . Patients &gt; 18 year age . 2 . Symptoms STEMI least 30 min within previous 12 hour AND STsegment elevation least 2 contiguous lead new Left Branch Bundle Block ( LBBB ) , OR exist LBBB positive troponin Residual high grade stenosis associate abnormality regional wall motion . 3 . Planned primary PCI native coronary vessel . 1 . Confirmed pregnancy 2 . Fibrinolytic therapy Any alteplase , reteplase , tenectoplase , streptokinase within last 24 hour 3 . Culprit lesion within SVG bypass conduit 4 . Dependency renal dialysis 5 . Administration LMWH within 8 hour prior PCI 6 . Administration abciximab within 7 day prior PCI 7 . Administration eptifibatide tirofiban within 12 hour prior PCI 8 . Warfarin MUST BE discontinue prior procedure , INR must ⎕1.5 , PT &lt; 15 , 9 . Heparin . If heparin administer ER long discontinue least 30 minute prior procedure , OR ACT &lt; 250 , patient may enrol . No clot measurement require patient receive heparin ⎕30 minute prior initiation bivalirudin . 10 . Allergy heparin bivalirudin , know sensitivity component product 11 . Allergy aspirin , clopidogrel , abciximab 12 . Contraindication abciximab 13 . Angiomax within 24 hour prior study drug administration 14 . Neurosurgery three month 15 . Severe hypertension adequately control antihypertensive therapy time study entry ( BP &gt; 180/110 mm Hg ) 16 . Cardiogenic shock ( SBP &lt; 80 &gt; 30 min need intravenous pressor ) 17 . Stroke within three month 18 . Any hemorrhagic diathesis 19 . Life expectancy &lt; 1 year 20 . Participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>ST-Segment Elevation</keyword>
	<keyword>Acute Myocardial Infarction</keyword>
	<keyword>PCI</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
</DOC>